A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer.
Saved in:
| Title: | A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer. |
|---|---|
| Authors: | Zhou, Mingzhen1,2, Jin, Yuncheng1, Zhu, Sihui3, Xu, Chen3, Li, Lin1,2,4, Liu, Baorui1,2 baoruiliu@nju.edu.cn, Shen, Jie1,2,5 shenjie2008nju@163.com |
| Source: | Clinical & Translational Immunology. 2024, Vol. 13 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20500068 |
|---|---|
| DOI: | 10.1002/cti2.1483 |
